Functional Polymorphisms in FAS/FASL System Increase the Risk of Neuroblastoma in Chinese Population

• DOI: 10.1371/journal.pone.0071656
• Publication Date: 2013-08-12T21:10:57Z
• Authors: Wei Han; Yuling Zhou; Rong Zhong; Chen Wu; Ranran Song; Li Liu; Li Zou; Yan Qiao; Kan Zhai; Jiang Chang; Liming Huang; Li Liu; Xuzai Lu; Jiao Lou; Dianke Yu; Wen Tan; Jinzhe Zhang; Huanmin Wang; Xiaoping Miao
• Keywords: Adult; Male; 0301 basic medicine; China; Fas Ligand Protein; Genotype; Science; Polymorphism, Single Nucleotide; Neuroblastoma; 03 medical and health sciences; Asian People; Gene Frequency; Humans; Genetic Predisposition to Disease; Alleles; Aged; Neoplasm Staging; Q; R; Infant, Newborn; Infant; Middle Aged; 3. Good health; Case-Control Studies; Child, Preschool; Medicine; Female; Research Article

The FAS and FASL system plays a substantial role in apoptosis and immune escape of cells. Three polymorphisms located in the promoter regions of FAS (-1377G/A and -670A/G) and FASL (-844T/C) have been shown to alter the transcriptional activity of the genes, respectively. This study was conducted to evaluate the effects of these polymorphisms on the susceptibility of neuroblastoma in the Chinese population. A total of 203 patients with neuroblastoma and 411 controls were recruited in this case-control study. Polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) was applied for genotyping. Unconditional logistic regression was used to estimate cancer risk by calculating odds ratios (ORs) and their 95% confidence intervals (95% CIs). It was observed that significantly increased risks of neuroblastoma associated with FAS -1377G/A and FASL -844T/C polymorphisms, with ORs equal to 1.55 (95% CI, 1.10-2.20) for FAS -1377 A allele and 2.90 (95% CI, 2.04-4.12) for FASL -844CC genotype carriers compared with non-carriers, respectively. However, no association was found between the polymorphisms of FAS -670A/G and risk of neuroblastoma. In addition, the cumulative effect of FAS and FASL polymorphisms on risk of neuroblastoma was observed (P for trend = 2.502×10(-10)), with OR for the carriers of both FAS -1377A allele and FASL -844CC genotypes equaled to 3.95 (95% CI, 2.40-6.51). This work reveals that polymorphisms of FAS -1377G/A and FASL -844T/C but not FAS -670A/G are associated with risk of neuroblastoma in Chinese. These findings support the hypothesis that genetic polymorphism in FAS/FASL death system may influence individual susceptibility to neuroblastoma.